Delirium with severe symptom expression related to hypercalcemia in a patient with advanced cancer: an interdisciplinary approach to treatment

被引:20
作者
Delgado-Guay, Marvin Omar [1 ]
Yennurajalingam, Sriram [1 ]
Bruera, Eduardo [1 ]
机构
[1] Univ Texas MD Anderson Canc Ctr, Dept Palliat Care & Rehabil Med, Houston, TX 77030 USA
关键词
delirium; symptom distress; hypercalcemia;
D O I
10.1016/j.jpainsymman.2007.11.004
中图分类号
R19 [保健组织与事业(卫生事业管理)];
学科分类号
摘要
Delirium is considered to be multifactorial, especially in elderly patients and those with advanced cancer, and can cause significant distress. High baseline vulnerability at the end of life, combined with cachexia, hepatic impairment, general comorbidities, and impaired functional status, can make delirium difficult to correct. Nonetheless, approximately 50% of delirium episodes are potentially reversible and reversible causes should be investigated. Hypercalcemia is one of the reversible metabolic causes of delirium in patients with advanced cancer. Here, we present the case of a patient with metastatic small cell prostate carcinoma who presented to our palliative care clinic with uncontrolled symptoms. A thorough evaluation using appropriate assessment tools revealed that he had delirium, and hypercalcemia was found to be the major etiologic factor. An interdisciplinary team approach (including a nutritionist, pharmacist, counselor, social worker, chaplain, and case manager) was provided. With aggressive symptom management and correction of hypercalcemia and other reversible causes of delirium, the delirium was resolved and the symptoms were controlled. This case illustrates the importance of screening for delirium in patients with severe symptom distress and how the interdisciplinary management of reversible causes of delirium, including hypercalcemia, can improve patients' symptoms and quality of life.
引用
收藏
页码:442 / 449
页数:8
相关论文
共 45 条
  • [1] SMALL-CELL CARCINOMA OF THE PROSTATE - IMPLICATIONS FOR MANAGEMENT
    ADSHEAD, F
    DEGRAEFF, A
    MANSI, JL
    THOMAS, DM
    SMITH, IE
    [J]. BRITISH JOURNAL OF UROLOGY, 1991, 67 (02): : 217 - 219
  • [2] Ifosfamide neuropsychiatric toxicity in patients with cancer
    Alici-Evcimen, Yesne
    Breitbart, William S.
    [J]. PSYCHO-ONCOLOGY, 2007, 16 (10) : 956 - 960
  • [3] Hypercalcemia of malignancy
    Body, JJ
    [J]. SEMINARS IN NEPHROLOGY, 2004, 24 (01) : 48 - 54
  • [4] COGNITIVE FAILURE IN PATIENTS WITH TERMINAL CANCER - A PROSPECTIVE-STUDY
    BRUERA, E
    MILLER, L
    MCCALLION, J
    MACMILLAN, K
    KREFTING, L
    HANSON, J
    [J]. JOURNAL OF PAIN AND SYMPTOM MANAGEMENT, 1992, 7 (04) : 192 - 195
  • [5] THE ASSESSMENT OF PAIN INTENSITY IN PATIENTS WITH COGNITIVE FAILURE - A PRELIMINARY-REPORT
    BRUERA, E
    FAINSINGER, RL
    MILLER, MJ
    KUEHN, N
    [J]. JOURNAL OF PAIN AND SYMPTOM MANAGEMENT, 1992, 7 (05) : 267 - 270
  • [6] THE ENDOCRINE COMPONENT OF PROSTATIC CARCINOMAS, MIXED ADENOCARCINOMA-CARCINOID TUMORS AND NON-TUMOR PROSTATE - HISTOCHEMICAL AND ULTRASTRUCTURAL IDENTIFICATION OF THE ENDOCRINE-CELLS
    CAPELLA, C
    USELLINI, L
    BUFFA, R
    FRIGERIO, B
    SOLCIA, E
    [J]. HISTOPATHOLOGY, 1981, 5 (02) : 175 - 192
  • [7] Delirium in advanced cancer patients
    Centeno, C
    Sanz, A
    Bruera, E
    [J]. PALLIATIVE MEDICINE, 2004, 18 (03) : 184 - 194
  • [8] Hypercalcaemia of malignancy and basic research on mechanisms responsible for osteolytic and osteoblastic metastasis to bone
    Clines, GA
    Guise, TA
    [J]. ENDOCRINE-RELATED CANCER, 2005, 12 (03) : 549 - 583
  • [9] Lesson of the week - Hypercalcaemia in cancer
    Conroy, S
    O'Malley, B
    [J]. BRITISH MEDICAL JOURNAL, 2005, 331 (7522): : 954 - 954
  • [10] Clinical subtypes of delirium and their relevance for daily clinical practice: a systematic review
    de Rooij, SE
    Schuurmans, MJ
    van der Mast, RC
    Levi, M
    [J]. INTERNATIONAL JOURNAL OF GERIATRIC PSYCHIATRY, 2005, 20 (07) : 609 - 615